Department of Agricultural and Biological Engineering, The Pennsylvania State University, University Park, PA, 16802, USA.
Faculty of Science and Engineering, The University of Waikato, Hamilton, 3240, New Zealand.
Bioprocess Biosyst Eng. 2017 Oct;40(10):1507-1517. doi: 10.1007/s00449-017-1807-x. Epub 2017 Jun 30.
Menaquinone-7 (MK-7), a subtype of vitamin K, has received a significant attention due to its effect on improving bone and cardiovascular health. Current fermentation strategies, which involve static fermentation without aeration or agitation, are associated with low productivity and scale-up issues and hardly justify the commercial production needs of this vitamin. Previous studies indicate that static fermentation is associated with pellicle and biofilm formations, which are critical for MK-7 secretion while posing significant operational issues. Therefore, the present study is undertaken to evaluate the possibility of using a biofilm reactor as a new strategy for MK-7 fermentation. Bacillus species, namely, Bacillus subtilis natto, Bacillus licheniformis, and Bacillus amyloliquifaciens as well as plastic composite, supports (PCS) were investigated in terms of MK-7 production and biofilm formation. Results show the possibility of using a biofilm reactor for MK-7 biosynthesis. Bacillus subtilis natto and soybean flour yeast extract PCS in glucose medium were found as the most potent combination for production of MK-7 as high as 35.5 mg/L, which includes both intracellular and extracellular MK-7.
甲萘醌-7(MK-7)是维生素 K 的一种亚型,由于其改善骨骼和心血管健康的功效而受到广泛关注。目前的发酵策略涉及不充气或搅拌的静态发酵,存在生产效率低和放大问题,几乎不能满足这种维生素的商业生产需求。先前的研究表明,静态发酵与菌膜和生物膜的形成有关,菌膜和生物膜的形成对 MK-7 的分泌至关重要,但同时也带来了重大的操作问题。因此,本研究旨在评估生物膜反应器作为一种新的 MK-7 发酵策略的可能性。本研究考察了纳豆芽孢杆菌、地衣芽孢杆菌和解淀粉芽孢杆菌以及塑料复合材料载体(PCS)在 MK-7 生产和生物膜形成方面的可能性。结果表明,生物膜反应器在 MK-7 生物合成方面具有应用潜力。在葡萄糖培养基中,纳豆芽孢杆菌和豆粕酵母提取物 PCS 被发现是生产 MK-7 的最佳组合,产量高达 35.5mg/L,包括细胞内和细胞外的 MK-7。